Blog

Dr. Kelly Meza-Capcha was accepted into the ASH Minority Resident Hematology Award Program

Photo of Kelly Meza from BCM Department of Medicine/X

May 25, 2024, 13:52

Dr. Kelly Meza-Capcha was accepted into the ASH Minority Resident Hematology Award Program

Kelly Meza, Research assistant at shared a post by BCM Department of Medicine on X/Twitter:

“So happy for this amazing opportunity ASH.

So grateful for amazing mentors who inspire me to pursue my dreams and my program BCM IM Residency for their great support.”

Quoting BCM Department of Medicine’s post:

“We are proud to recognize Dr. Kelly Meza-Capcha for being accepted into the American Society of Hematology (ASH) Minority Resident Hematology Award Program! This achievement provides an opportunity for hands-on research and further exposure to hematology.”

Source: Kelly Meza/X and BCM Department of Medicine/X

American Society of Hematology ASH BCM Department of Medicine BCM IM Residency cancer Dana-Farber Cancer Institute Kelly Meza-Capcha Minority Resident Hematology Award Program OncoDaily Oncology

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage